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Background. CARD15/NOD2 mutations are associated with susceptibility to Crohn’s Disease (CD) and Graft Versus Host
Disease (GVHD). CD and GVHD are suspected to be related with the dysfunction of Peyer’s patches (PP) and isolated lymphoid
follicles (LFs). Using a new mouse model invalidated for Card15/Nod2 (KO), we thus analysed the impact of the gene in these
lymphoid formations together with the development of experimental colitis. Methodology/Principal Findings. At weeks 4,
12 and 52, the numbers of PPs and LFs were higher in KO mice while no difference was observed at birth. At weeks 4 and 12,
the size and cellular composition of PPs were analysed by flow cytometry and immunohistochemistry. PPs of KO mice were
larger with an increased proportion of M cells and CD4
+ T-cells. KO mice were also characterised by higher concentrations of
TNFa, IFNc, IL12 and IL4 measured by ELISA. In contrast, little differences were found in the PP-free ileum and the spleen of KO
mice. By Ussing chamber experiments, we found that this PP phenotype is associated with an increased of both paracellular
permeability and yeast/bacterial translocation. Finally, KO mice were more susceptible to the colitis induced by TNBS.
Conclusions. Card15/Nod2 deficiency induces an abnormal development and function of the PPs characterised by an
exaggerated immune response and an increased permeability. These observations provide a comprehensive link between the
molecular defect and the Human CARD15/NOD2 associated disorders: CD and GVHD.
Citation: Barreau F, Meinzer U, Chareyre F, Berrebi D, Niwa-Kawakita M, et al (2007) CARD15/NOD2 Is Required for Peyer’s Patches Homeostasis in
Mice. PLoS ONE 2(6): e523. doi:10.1371/journal.pone.0000523
INTRODUCTION
Caspase Recruitment Domain 15 (CARD15) also known as
Nucleotide oligomerisation domain 2 (NOD2) has been associated
with Crohn’s Disease (CD) [1,2] and graft versus host disease
(GVHD) [3,4]. NOD2 belongs to a family of genes involved in
innate immunity [5]. It can be activated by muropeptides which
are components of the bacterial cell wall. When activated, NOD2
interacts with Rick/Rip2 which in turn activates the NF-kB
pathway, resulting in the production of pro-inflammatory
cytokines.
Half of CD patients have one or more NOD2 mutations [6].
Some of the CD associated mutations were found unresponsive to
muropeptides [5]. By consequence, CD is usually considered as an
immune deficiency toward bacteria present in the gut lumen [7].
However, the exact mechanism by which NOD2 mutations are
able to induce CD lesions is still subject to debate [7–10].
Holler et al. reported that the three major mutations associated
with CD (R702W, G908R and 1007fs) are also associated with
severe acute GVHD and bone marrow transplantation (BMT)
related mortality [3]. Mutations in both donor and recipient were
found deleterious, suggesting a role of epithelial and circulating
cells in disease mechanisms. Despite some differences in their
conclusions, other groups recently confirmed the association
between NOD2 and BMT complications [4,11].
CD is a chronic relapsing inflammatory bowel disease (IBD)
with mucosal ulcerations of the digestive tract. CD lesions are
characterised by a T helper (Th) 1 immune response and several
authors have shown that they are related with gut associated
lymphoid tissue (GALT), known as lymphoid follicles (LFs). LFs
are mainly encountered in the colon where they are isolated and in
small bowel where they are grouped forming Peyer’s patches (PP)
which are known to be pivotal sites for the host immune response
and for the entry of enteropathogen bacteria. CD lesions are most
often localized in colon and distal ileum, where the LFs are the
most abundant [12]. Fujimura et al. found that aphtoı ¨d ulcerations
(which are often considered as the earliest CD lesions) are centred
by LFs [13]. In addition to this spatial relationship, a temporal link
between CD and PP development has also been suggested [14].
PPs develop from birth to 10–15 years of life and then undergo
involution. The age-dependent incidence curve of CD is roughly
parallel to the number of PP with a delay of about 10 years.
Finally, ileal lesions are uncommon in young children and seniors
where PP are rare [15,16].
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experimental models and clinical observations. Animal studies
showed that death after BMT was prevented by gut decontam-
ination and that prevention of mucosal damage also prevents
lethal GVHD [17]. In clinical practice, gut decontamination
reduces the frequency and severity of GVHD. Finally, Murai et al.
recently showed that PP deficient mice are resistant to GVHD,
arguing for a crucial role of PPs in GVHD, at least in models that
do not use conditioning of the host prior to adoptive transfer of the
allogeneic donor cells [18,19].
Considering all these elements, we hypothesized that Nod2 may
play a role in the structure and function of the GALT.
Consequently, we used a new mouse model deficient for
Card15/Nod2 i) to evaluate the involvement of Nod2 on the
number and PPs size; ii) to assess whether Nod2 modified cellular
composition and cytokine expression of PPs; and iii) to determine
whether Nod2 may alter paracellular permeability and bacterial
translocation of PPs in adult mice. Finally, we also examined if
Card15/Nod2 deficiency affects the colonic response to 2,4,6-
trinitrobenzene sulphonic acid (TNBS), a classic experimental
model of colitis in mouse.
RESULTS
Body weight, intestinal length and intestinal weight were similar in
KO and WT mice (supplementary information (SI) Table S1).
Macroscopically, no inflammation was visible in KO mice
according to Wallace and Ameho criteria (data not shown). KO
mice exhibited an increased number of PP in comparison with
WT mice at weeks 4, 12 and 52 after birth (Fig 1 A). At weeks 12
Figure 1. Nod2 and postnatal development of gut associated lymphoid formations. (A) PP count on the whole intestines of KO (&) and WT (%)
mice at birth and at weeks 4, 12 and 52. (B) Number of isolated LFs identified on microscopic examination of the small intestine at weeks 12 and 52.
(C and D) Number of cells per PP and spleen at weeks 4, 12 and 52). (E) Number of apoptotic cells identified by caspase-3 immunostaining at week 12.
Data represent the means6SEM of 8 mice per group. *P,0.05; **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0000523.g001
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higher in KO mice than in WT mice (Fig 1 B). In contrast, the
number of PPs at birth was similar between KO and WT mice
(6.260.5 vs. 6.060.4; P.0.05) (Fig 1 A).
Macroscopically, the size of PP formations appeared to be larger
in adult KO mice (data not shown). To quantify this difference, the
three biggest PPs of each mouse were pooled and their cells were
counted. At weeks 4, 12 and 52, KO mice exhibited a higher cell
number per PP (fig 1 C). In contrast, cell counts were comparable
in spleens of KO and WT mice (Fig 1 D).
Microscopic analyses of PP formations from KO mice revealed
no gross abnormalities (Fig 1 E). Finally, as NOD2 modulates the
NF-kappaB pathway and putatively the apoptosis, we investigated
the number of apoptotic cells inside PPs. Immunohistochemistry
experiments did not show differences between KO and WT mice
for the number of caspase 3 positive cells (1.0160.11 vs.
1.3260.10; P.0.05) (Fig 1 E).
In order to better characterise the phenotype of the cells present
in PPs, we performed flow cytometry experiments using the B220,
CD3 and CD11c antibodies. At week 12, no differences were seen
regarding the relative proportions of B220
+ B-cells, CD3
+ T-cells
and CD11c
+ dendritic cells between KO and WT mice either for
PPs or spleens (Fig 2 A–B).
Because some cells present in a limited number may be
functionally important, we also investigated the relative proportion
of Ly-6G
+ polymorphonuclear neutrophils (PMN) present in the
PPs (Fig 2 C) and the number of M cells located inside the follicle
associated epithelium (FAE) (Fig 2 D). No difference of PMN
Figure 2. Nod2 and Peyer’s patch cellular composition. (A and B) Relative proportions of T-, B- and dendritic cells from PPs and spleens of KO (&)
and WT (%) mice at week 12. T-, B- and dendritic cells were investigated by flow cytometry using antibodies to CD3, B220 and CD11c. (C) Relative
proportion of polymorphonuclear neutrophils was analyzed using Ly-6G antibody. (D) M cells number inside the follicle associated with epithelium
was investigated by immuno-histochemistry. Arrows indicated the presence of M-cell inside the follicle associated with epithelium. Data represent
the means6SEM of 8 mice per group. **P,0.01.
doi:10.1371/journal.pone.0000523.g002
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C). At the opposite, M cell number was increased in the FAE of
KO mice in comparison with WT mice (Fig 2 D).
As T-cells are known to play a pivotal role in CD, we further
analyzed the CD3
+ T cells. At week 12, KO mice exhibited an
increase of CD4
+ T-cell relative proportion within their PPs,
whereas the proportion of CD8
+ T-cells remained constant (Fig 3
A). As a mirror image, PPs from KO mice exhibited significantly
fewer CD3
+CD4
2CD8
2 T-cells (Fig 3 A). In contrast, no
comparable differences were seen in the spleens (Fig 3 B). Similar
data were obtained at week 4 (SI Fig S1 A–B).
Finally, we investigated the phenotype of CD4
+ T-cells present
in the PPs and spleens by examining the relative proportions of
naive CD25
2CD45Rb
+, regulatory CD25
+CD45Rb
2 and mem-
ory CD25
2CD45Rb
2 CD4
+ T-cells. KO and WT mice had
a similar relative proportion of naive, regulatory and memory
CD4
+ T-cells in PPs (SI Fig S2 A) and spleen (SI Fig S2 B). Flow
cytometry analyses also failed to reveal a difference between KO
and WT mice when investigating the annexin V positive CD3
+
and CD3
+CD4
+ T-cells extracted from PPs (SI Fig S2 C)
suggesting that the excess of CD4
+ T-cells observed in KO mice
does not result from a defect of apoptosis.
Considering the differences of PP cell number and cellular
composition, we further evaluated whether PPs from KO and WT
mice might exhibit differences regarding their cytokine profile.
Thus, the expression of IL-1b, IFNc, TNFa , IL-12, and IL-4 in
PPs, PP-free ileum and spleen were determined by ELISA, at
weeks 4 and 12. Levels of IFNc, TNFa, IL-12, and IL-4 were
significantly increased in PPs of KO mice (Fig 4). In contrast, less
marked differences were seen between KO and WT mice in PP-
free ileum where TNFa and IFNc were the only cytokines
differentially expressed at week 4 but not in adult mice (Fig 4).
Finally, no differences were observed in spleens from KO and WT
mice (Fig 4).
Cell composition and cytokine production may affect the
function of PPs. We thus used Ussing chambers for determining
the paracellular permeability through PP and PP-free ileum. PPs
and PP-free ileum of KO mice exhibited a significant increase in
paracellular permeability (Fig 5 A) while the electrical resistances
were comparable (data not shown). In parallel to this change,
mRNA expression levels of TJ proteins were affected in PP of KO
mice. Indeed, expression of mRNAs encoding ZO-2 and ZO-1
were decreased by 45% and 36% (P,0.01 and P,0.06 re-
spectively) (Fig 5 B). In contrast, Occludin expression was
unchanged (Fig 5 B).
Because Nod2 is involved in innate immunity we hypothesised
that Card15/Nod2 deficiency may affect the gut microflora. We
thus counted the numbers of bacteria classified as Enterobacteriaceae,
Pseudomonas, Staphylococcus, Streptococcus, Enterococcus or Lactobacillus in
the ileum of KO and WT mice. However, we did not observed
differences between groups (SI Table S2).
Ussing chamber experiments were also performed to investigate
the bacterial passage through PP. The passage of a chemically
killed Escherichia coli (K-12) was higher in PP of KO mice (P,0.01)
(Fig 5 C). This increased translocation was also observed using
living non pathogenic Escherichia coli strain J53 (Fig 5 D). In
contrast, translocation of Escherichia coli across free-PP ileum
mucosa was very low and not significantly increased (P.0.05, fig 5
C). The translocation through PPs of a chemically killed
Staphylococcus Aureus (Wood strain without proteinA) and Saccharo-
myces cerevisiae was also higher in KO than in WT mice (Fig 5 E and
F)).
TNBS colitis is a well studied model of acute colitis in mice but
no data are currently available in the literature on the effect of
Figure 3. Nod2 and T-cells subset in PP and spleen from mice at 12 weeks of age. Relative proportion of CD4
+, CD8
+ and CD4
2CD8
2 T-cells from
PPs (A) and spleen (B) of KO (&) and WT (%) mice. At week 12, CD3
+ T-cells were stained with antibodies to CD3, CD4, and CD8. Data were gated for
CD3
+ T-cells. Data represent the means6SEM of 8 mice per group. *P,0.05.
doi:10.1371/journal.pone.0000523.g003
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intracolonic instillation of TNBS, the body weight loss was higher
in KO than in WT mice but this difference did not reach
significance (Fig 6 A). Nevertheless, the colonic mucosal damage
score was higher in KO mice (Fig 6 B) as well as mucosal
concentrations of IL-1b, TNF-a and IL-12 (Fig 6 C).
DISCUSSION
Since the discovery of an association between CARD15/NOD2
mutations and both CD [1,2] and GVH [3,4], the pathophysio-
logical functions of CARD15/NOD2 involved in CD and GVHD
development are poorly understood [9]. However, because an
association between GALT dysfonctions and GVHD, as well as
spatial and temporal links between CD lesions and PP have been
suggested by several authors, we used a new model of Card15/Nod2
deficient mouse, to explore the impact of CARD15/NOD2 in PP
development and function. We observed that adult KO mice
exhibit an excess of PP and isolated LFs in the gut. PP from KO
mice are characterized by an excess of M cells and CD4
+ T-cells
and a higher expression of Th1 and Th2 cytokines. These
differences are associated with increased paracellular permeability
and bacterial and yeast passage through PPs. Finally, we observed
that Card15/Nod2 deficient mice are more susceptible to TNBS
induced colitis. As a whole, the here reported phenotype of the
Card15/Nod2 KO mouse is reminiscent to the observations made
in the Human diseases associated with CARD15/NOD2 mutations:
CD and GVHD.
Our data demonstrate first that Card15/Nod2 deficient mice
have an elevated number of PPs and isolated LFs after birth. As
intestinal weight and length are similar between KO and WT
mice, this finding does not seem to be secondary to an intestinal
overgrowth. In addition, PPs from deficient mice are larger, as
indicated by the macroscopic examination of the intestines and by
the count of PP cells. As a result, Card15/Nod2 modulates the
development of the GALT and Card15/Nod2 deficiency is
characterised by an overgrowth of the lymphoı ¨d tissue present in
the gut. This over-development of the lymphoı ¨d tissue seems to be
specific to the GI tract as non significant change were observed in
a systemic immune organe like spleen. The lack of difference in PP
number between WT and KO mice at birth indicates that Card15/
Nod2 plays its role during post natal development of the GALT.
While lymphotoxin and IL-7 signalling are essential for the
organogenesis of PP during the embryonic stage [20–22], it is
widely believed that gut commensal bacteria are critical for the
postnatal development of gut mucosal immune system, as
demonstrated by studies on germ-free animals [23]. Such animals
have an underdeveloped GALT and are resistant to experimental
colitis and to severe GVHD [18]. Thereby, pattern recognition
receptors, including TLRs and NOD molecules, can be seen as
good candidates by which the resident flora stimulates the
development of GALT. However, TLRs play only a limited role
in PP development at early postnatal stage in mice [24]. At the
opposite, our data suggest that Card15/Nod2 plays a pivotal role in
the postnatal development of GALT.
Because gut flora is important in PP development, it can be
questioned if Card15/Nod2 deficiency affects gut flora composition
of the host. In order to answer this question, we counted the
bacteria most represented in the ileum and able to cultivate in
standard conditions. We failed to demonstrate differences between
KO and WT mice suggesting that Card15/Nod2 deficiency does
not induce gross abnormalities of the gut microflora. However,
more discrete alterations cannot be discarded and additional
experiments using germ-free animals and/or molecular methods
for bacterial detection are required to further explore the
relationship between Card15/Nod2 and the normal gut flora.
PPs have B-cell follicles and germinal centres surrounded by
areas that contain predominantly T cells. The analysis of the PP
from Card15/Nod2 deficient mice failed to reveal gross abnormal-
ities in terms of microachitecture, apoptosis or cell composition (at
least for the three main cell lineages present in PP, namely B-cells,
T-cells and dendritic cells). This observation is in accordance with
the previous descriptions of other Card15/Nod2 KO models of
mice which failed to reveal gross intestinal abnormalities under
basal conditions [7,25]. Interestingly, the phenotype observed in
the deficient mouse is reminiscent with the Human CD condition
Figure 4. Nod2 invalidation increases cytokine expression in PP.
Expressions of Il-1b, IFNc, TNFa, IL-12, IL-4 were determined by ELISA in
PPs, Ileum and spleens from KO (&) and WT (%) mice at weeks 4 (left
panel) and 12 (right panel). Data represent the means6SEM of 8 mice
per group. *P,0.05; **P,0.01.
doi:10.1371/journal.pone.0000523.g004
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and cell composition have been reported [26].
LFs are covered by a specialised epithelium including M cells.
These cells are able to transfer bacterial and food antigens from
the gut lumen to antigen presenting cells [23]. They have thus
a pivotal role in the function of PP. M cells were found more
numerous in KO mice. In addition, PP of KO mice exhibited
a higher proportion of CD4
+ T-cells and a decreased percentage
of CD3
+CD8
2CD4
2 T-cells. As Nod2 may modulate the
apoptosis, we have hypothesized that this increase of CD4
+ T-
cell number may result from an apoptosis defect in the lymphoid
cells of KO mice. However, flow cytometry analyses revealed that
Figure 5. Paracellular permeability and bacterial translocation are increased in Nod2 invalidated mice. Ussing-chamber and Real-time PCR
experiments were performed on PP and PP-free ileum from WT (%) and KO (&) at week 12. (A) Paracellular permeability was analysed by FITC-
dextran flux from PP and PP-free ileum under basal condition. (B) mRNA expression levels of TJ proteins (ZO-1, ZO-2 and Occ) from PP were analysed
by real-Time-PCR under basal condition. (C) Bacterial translocation of chemically killed fluorescent Escherichia Coli K-12. (D) Translocation of the viable
non enteropathogen Escherichia Coli strain J53. (E) Translocation of a chemically killed fluorescent Staphylococcus Aureus. (F) Translocation of
chemically killed fluorescein-conjugated Saccharomyces cerevisiae. Data represent the means6SEM of 8 mice per group. *P,0.05 and **P,0.01,
significantly different from WT.
doi:10.1371/journal.pone.0000523.g005
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+ T-cells from PP was
similar between KO and WT mice. As a result, our experiments
do not support the opinion that Card15/Nod2 deficiency is
characterised by a general apoptosis defect in the lymphoid tissue
of KO mice. Finally, the altered immune cell composition is
concomitant with an increase of pro-inflammatory Th1 but also
anti-inflammatory Th2 cytokine expression. Altogether, these
results indicate that under basal condition, PPs of KO mice are
characterised by an exaggerated immune response.
Cell composition and cytokine production may affect the
function of PP. We thus used Ussing chambers for determining
the paracellular permeability through PP and PP-free ileum. KO
mice exhibited a significant increase of paracellular permeability.
This result is in accordance with the altered intestinal permeability
reported in CD patients and their healthy relatives, especially in
case of CARD15/NOD2 mutations [27–30]. Pro- and anti-
inflammatory cytokines are known to modulate intestinal para-
cellular permeability. IFNc, TNFa and IL-4, act on membrane
receptors of epithelial cells to increase tight junction permeability
[31–34]. For example, on T84 cells IFNc decreased levels of ZO-1
and altered apical actin organisation, which leads to disorganisa-
tion of TJ and increased permeability [35]. Similarly, PP from KO
mice exhibited a decrease of ZO-1 and ZO-2 mRNA expression in
comparison with WT mice. Consequently, the excessive concen-
tration of IFNc observed in KO mice may down regulate the
transcription of ZO-1 and ZO-2 mRNA expression and contribute
to the increase paracellular permeability in KO mice. It is to note
that this phenotype is reminiscent to the CARD15/NOD2
associated Human disorders. Indeed, in CD patients, increased
permeability has been reported to be mediated by TNFa and to
precede the clinical relapse while GVHD has been treated by anti-
TNF antibodies [36,37].
Because of the changes in gut permeability, we finally studied
the role of Card15/Nod2 in bacterial translocation. Bacterial
passage of Staphylococcus aureus and Escherichia coli and yeast ingress
of Saccharomyces cerevisiae were higher through PP of KO mice. It is
widely accepted that CD is related with an excessive bacterial
translocation through the intestinal epithelium even if this
hypothesis is not perfectly documented. The present data further
support this opinion. In addition, this excess of yeast and bacteria
translocation through PP of KO mice is in agreement with recent
reports showing that mutated CD patients and their unaffected
relatives develop more frequently antibodies to Saccharomyces
cerevisiae, Pseudomonas fluorescens–related protein, Escherichia coli outer
Figure 6. Nod2 invalidation increased the suceptibility of TNBS induced colitis. (A) Body weight, (B) Macroscopic damage score, (C) cytokines levels
were assessed in 12 week old mice. These parameters were determined three days after intracolonic administration of TNBS. Values are mean (SEM)
(n=8 in each group). *P,0.05 and **P,0.01 between WT and KO mice.
doi:10.1371/journal.pone.0000523.g006
NOD2 and Peyer’s Patches
PLoS ONE | www.plosone.org 7 June 2007 | Issue 6 | e523membrane porin C and CBir1 flagellin [38]. The excessive
bacteria and yeast passage reported here may participate in the
enhancement of adaptive immune responses to microbial antigens.
The increased number of M cells can contribute to the high
translocation rate observed in KO mice. However, because M cell
differentiation is inducible by microbial challenge [39], it may also
be a consequence of bacterial translocations and additional
experiments are required to further dissect this complex relation-
ship. It is also possible to consider that CARD15/NOD2
dysfunction facilitates bacterial entry through defective antibacte-
rial peptide expression [7], impaired intracellular bactericidal
capacity or reduced epithelial immune defence. Finally, bacterial
translocation may also be secondary to primitive local cytokine
changes. IFNc is known to increase the epithelial adherence of
selected species of enteric bacteria [40]. Ferrier et al. have shown
that a chronic stress in mice drives an organ-specific cytokine
Figure 7. Targeting disruption of the murine Nod2 gene by homologous recombination. (A) Generation of the Card15/Nod2 KO allele: targeting
strategy. The restriction maps of the Card15/Nod2+allele (59 portion), the Card15/Nod2 KO targeting fragment, and the modified Card15/Nod2 allele
after homologous recombination and Cre-mediated recombination of an Hygromycin selection cassette are shown. Exons 1, 2, and 3 (black boxes)
and restriction sites used for cloning and screening (X) XbaI, (A) AgeI, (P) PmlI, (S) SalI, (N) NotI are indicated. The Card15/Nod2 KO targeting fragment
comprises the EGFP gene (Clontech) in frame with Card15/Nod2 ATG and the floxed PGKHygromycin (Clontech) selection cassette, introduced
between the AgeI site downstream of Card15/Nod2 exon 1 and the SalI site upstream of exon 1 in the Card15/Nod2 orientation. All loxP sites are
represented by open triangles. Recombination of loxP1 and loxP2 results in the loxP1+2 site. In the first step of the strategy, the Card15/Nod2 locus
was targeted with the Card15/Nod2 KO targeting fragment. In the second step, the PGKHygromycin selection cassette was removed by Cre
recombinase. The double-headed arrows indicate the DNA fragments resulting from digestions with different enzymes expected to hybridize with
probes A, B or Hyg. Also depicted are combinations of PCR primers P1-4 that detect the different Card15/Nod2 alleles. (B) Southern blot analysis of
restricted DNA resulting from digestion with XbaI.Hybridation with Probe A and B show complete integration of the targetting fragment after
homologous recombination. Probe Hyg show the differents integrations of targetting fragments after homologous recombination. (C) Genotyping of
Nod2-deficient mice by PCR. Genomic DNA from mice was amplified by PCR to detect the disrupted sequence (PCR product of 459 bp). (D)
Expression of Nod2 mRNA in spleen. RT-PCR was performed on purified mRNA from the spleen of WT and KO mice. As expected, no signal was
observed in KO mice. GAPDH expression was used as positive control of expression.
doi:10.1371/journal.pone.0000523.g007
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barrier functions and favours bacterial translocation [31]. This
effect is dependent on the presence of CD4
+ T-cells and requires
IFNc production. It is thus possible that bacterial translocation is
a result of the immune changes rather than its cause and
additional experiments are now required to answer this question.
Finally, we have shown that Card15/Nod2 invalidation exacer-
bates the severity of TNBS induced colitis, as evidenced by the
increase in all parameters characterising colonic inflammation
(damages scores and mucosal levels of IL-1b, TNFa and IL-12).
This enhanced colitis-induced by TNBS might be explained by
different mechanisms. Firstly, since microflora is required for
TNBS-induced colonic mucosal damages and since Card15/Nod2
signaling has been shown to inhibit the TLR2-driven activation of
Th1 response [8], one can hypothesize that the Th1 inflammatory
response mediated by TLR-2 is increased in Card15/Nod2 deficient
mice. Secondly, since GALT is reported to modulate the severity
of TNBS-induced colitis [41,42] it can be hypothesised that the
TNBS induced colitis is exacerbated in Card15/Nod2 KO mice
because of GALT overdevelopment. Finally, an alternative
explanation could be that the observed defect in terms of intestinal
permeability and bacterial translocation makes the intestine more
susceptible to TNBS.
Altogether, the present data demonstrate that Card15/Nod2 is
required to maintain the homeostatis of the PPs. Because
CARD15/NOD2 is a well demonstrated etiological factor for
CD/GVHD, this conclusion is of particular importance for the
understanding of disease mechanisms. Indeed, it further supports
the opinion that the defect involved in the development of the gut
lesions is related with PP and LF function. The GALT dysfunction
observed in KO mice is associated with an excessive gut immune
response and an increased bacterial translocation. These findings
are consistent with our knowledge on the Human diseases associated
with CARD15/NOD2 mutations namely GVHD and CD and for
which similar observations have been reported. As a result, the
phenotype of the Card15/Nod2 KO mice can be seen as an
attenuated model of CD/GVHD. It is to note that the absence of
a full phenotype is not unexpected considering the multifactorial
nature of the Human diseases where exposure to several additional
unknown genetic and environmental risk factors is required for
disease expression. At the opposite, our work indicates that the
Card15/Nod2 KO mouse is a relevant model for investigating these
other risk factors associated with CD and GVHD.
MATERIAL AND METHODS
Animals
Card15/Nod2 was disrupted in mice by replacing the first coding
exon carrying the majority of the sequence encoding the CARD
domains including the start codon with a EGFP cassette. (Fig. 7 A).
In the first step of the strategy, the Card15/Nod2 locus was targeted
with the Card15/Nod2 KO targeting fragment. In the second step,
the PGKHygromycin selection cassette was removed by Cre
recombinase. Targeted disruption was determined by Southern
blot and long-range PCR analysis (Fig. 7 B–C). Genomic DNA
from mice was amplified by PCR using the primers: 5-GTCA-
TTTCCTGACCTCTGACC-3 and 5-AACCGCATTATTC-
CATGGGGC-3 to detect WT DNA and primers 5-AACCG-
CATTATTCCATGGGGC-3 and 5-GCCTGCTCTTTACT-
GAAGGCTC-3 to detect the disrupted sequence. The loss of
mRNA Nod2 expression was demonstrated in splenocytes by RT-
PCR (Fig. 7 D) using the following primers: (5-CTTTGAACTG-
TATGGGTCC-3 and 5-CTCCACTGCCTCTGCCTTA-3). As
expected, no signal was observed in KO mice.
The Card15/Nod2
2/2 (KO) mice used for this study were back-
crossed five times with the inbred strains C57BL/6. WT and KO
mice were housed and generated in the animal facility at Robert
Debre ´ Hospital, Paris, France. The absence of enteropathogens
was monitored. All experiments were approved by the institutional
committee for animal use.
Peyer’s patches and isolated lymphoid follicle
numbers
The entire small intestines were removed and the number of PPs
was determinated by macroscopic observation except at birth
where PPs were too small to be seen by the naked eye. At birth,
small intestines were fixed in formalin, stained with 0.5%methy-
lene blue and decolorized in fresh 2% acetic acid. For LF counts,
small intestines were fixed in formalin and rolled up into a ‘Swiss-
roll’, embedded in paraffin blocks and cut into 5 mm sections. LFs
were counted in a blind fashion on two sections per blocks after
haematoxylin-eosin staining.
Cell composition of Peyer’s Patches and spleens
Cell suspensions from PPs were prepared by pressing the three
largest PPs for each mouse with a 5 ml syringe piston. The
preparation was then incubated with 100 U/ml collagenase D
(Roche, Mannheim, Germany) for 30 minutes at 37uC in DMEM
media. Cells from spleen were isolated using the same procedure
with an additional step of erythrocytes lysis (Gey’s-solution). After
centrifugation, cells were re-suspended in DMEM media and
submitted to flow cytometry analyses on a FACScalibur (Becton-
Dickinson), and analyzed by Cell Quest 3.3 (Becton Dickinson).
Monoclonal antibodies used to stain cell suspensions were
purchased from BD Biosciences (Pharmingen Heidelberg, Ger-
many) : PE-Cy5-anti-CD3 (17A2), PE-Cy7-anti-CD3 (145-2C11),
PE-Cy5-anti-CD4 (H129.19), PE-anti-CD4 (RM4), FITC-anti-
CD8 (53-6.7), PE-anti-CD11c (HL3), PE-anti-CD25, PE-anti-
CD45R/B220 (RA3-6B2), FITC-anti-CD45RB (16A), APC-anti-
annexin V and eBioscience (San Diego, CA) : APC-anti-Ly-6G
(RB6-8C5).
Immunohistochemistry
M cells were counted in the FAE using a fluorescence microscope
after immunostaining of PP cryostat sections (5 mm) with anti-Ulex
Europeaeus antibodies (1/250, 2 h) (Sigma, France), revealed by
anti-Ulex Europeaus agglutinin I (1/500, 30 min.) (Vector
laboratories) and anti-rabbit FITC conjugate (1/80, 30 min.)
(Sigma, France). Caspase 3 immunostaining was done using rabbit
polyclonal antibodies to Cleaved Caspase-3 (Asp 175, dilution: 1/
100) ( Cell Signaling Technology, Inc Ozyme, Beverly, MA, USA).
Cytokine Enzyme-Linked Immunosorbent Assay
(ELISA)
PPs, ileum and spleen from WT and KO mice were removed,
washed with cold PBS and the concentration of protein was
determined using commercial kit (Biorad, Marnes la Coquette,
France). TNFa, IFNc, IL-4 and IL-1b were determined by ELISA
assays (BD Biosciences) according to the manufacturer’s instruc-
tions. All experimental groups were tested in duplicates.
Ussing chamber experiments
Biopsies from ileum with or without PPs were placed in a chamber
exposing 0.196 cm
2 of tissue surface to 1.5 ml of circulating
oxygenated Ringer solution at 37uC. PP and ileum permeability
were assessed by measuring steady-state (from 1 to 2 h) mucosal-
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Fallavier, France). Bacterial translocation was studied using
chemically killed fluorescein-conjugated Escherichia coli K-12 or
Staphylococcus Aureus BioParticles (Molecular Probes, Leiden, the
Netherlands) or a viable Escherichia coli (the J53 strain resistant to
rifampicin) at a final concentration of 1.10
7 CFU/ml in the
mucosal reservoir. Saccharomyces cerevisiae translocation was studied
using chemically killed fluorescein-conjugated S. cerevisiae BioPar-
ticles (Molecular Probes, Leiden, the Netherlands) at a final
concentration of 1.10
7 CFU/ml in the mucosal reservoir.
Real time reverse transcription-polymerase chain
reaction (RT-PCR)
After extraction from PP of ileum by the NucleoSpinH RNA II Kit
(Macherey-Nagel, Hoerdt, France), total RNA was converted to
cDNA using random hexonucleotides and then used for PCR. We
conducted PCR with QuantiTect SYBR Green PCR Kit (Applied,
Courtaboeuf, France) using sense and antisense primers specific
for: G3PDH, 59-CACCATCTTCCAGGAGCGAG-39 and 59-
GCCTTCTCCATGGTGGTGAA-39; Occludin (Occ), 59-AGC-
CTTCTGCTTCATCGCTTC-39 and 59-GTGGCAATAAACA-
CCATGATGC-39; Zonula Occludens-1 (ZO-1), 59- GACTCCA-
GACAACATCCCGAA-39 and 59- AACGCTGGAAATAACC-
TCGTTC -39; Zonula Occludens-2 (ZO-2), 59-CAGCCACAAT-
CAACGTGAATTC-39 and 59-CTGTCCTTCAAGCTGCCAA-
AC-39. After amplification, we determined the threshold cycle (Ct)
to obtain expression values.
Bacterial content of ileum
The entire ileum (5 cm) was removed and ileal content was
collected using 3 mL of steril water (Biorad, France) administered
with a polypropylene syringe. Then, ileal content was homoge-
nized and serial dilution (50 mL) of each aliquot were plated onto 5
selective gelose (URI 4, Drigalski, Columbia ANC+5% of sheep
blood, Chapman and Coccosel). Plates were incubated for
24 hours at 37uC under aerobic condition and the number of
colony forming units was counted and expressed as cfu/mg of ileal
content.
TNBS induced colitis
Under anaesthesia colitis was induced in 12 week old mice by
a single intracolonic administration of 120 mg/kg TNBS (Sigma,
France) dissolved in 50% ethanol. A 50 ml aliquot of the freshly
prepared solution was injected into the colon, 4 cm from the anus,
using a 3.5 F polyethylene catheter. The mice were weighed and
killed 72 h after TNBS administration. Then, body weight,
macroscopic damage score according the Wallace scores [43],
and cytokines levels were assessed.
Statistical Analyses
Values are expressed as mean6SEM. Statistical analysis were
performed using GraphPad Prism 4.00 (GraphPad Software, San
Diego, CA, USA) software package for PC. Single comparisons
were performed by unpaired Student’s t-test. A value of P,0.05
was considered as statistically significant. All P values were two
sided.
SUPPORTING INFORMATION
Table S1 Impact of Nod2 on body weight, gut weight and
intestine length. At weeks 4, 12 and 52, we investigated the body
and gut weight and the intestine length of KO and WT mice. No
difference was observed between KO and WT mice (P.0.05).
Data represent the means6SEM of 8 mice per group.
Found at: doi:10.1371/journal.pone.0000523.s001 (0.03 MB TIF)
Table S2 Ileal microflora under basal condition. Under basal
condition, no difference was observed between KO and WT mice
(P.0.05 for each bacterial group). Data represent the mean-
s6SEM of 10 mice per group.
Found at: doi:10.1371/journal.pone.0000523.s002 (0.03 MB TIF)
Figure S1 PPs from KO mice exhibit higher rates of CD4+ and
CD4-CD8-T-cells at week 4. At week 4, CD3+ T-cells recovered
from PPs (A) and spleen (B) were stained with antibodies to CD3,
CD4, and CD8 from KO (&) and WT (%) mice. Data were gated
for CD3+ T-cells. Relative proportions of both CD3+CD4+ and
CD3+CD4-CD8- T-cells were significantly higher in the PPs but
not in the spleen (P.0.05) of KO mice. Data represent the
means6SEM of 8 mice per group. *P,0.05; **P,0.01.
Found at: doi:10.1371/journal.pone.0000523.s003 (0.08 MB TIF)
Figure S2 Nod2 and CD3+ T -cells in Peyer’s Patches. (A and B)
Relative proportions of naı ¨ve, regulatory and memory T-cells in
PPs (A) and spleens (B) of KO (&) and WT (%) mice at week 12.
CD4+ T-cells were stained with antibodies to CD25 and
CD45RB. (C) Relative proportions of apoptotic CD3+ and
CD3+CD4+ T-cells. Apoptotic CD3+ and CD3+CD4+ T-cells
were investigated by flow cytometry using antibodies to CD3, CD4
and annexin V. Data were gated for CD3+CD4+ T-cells. Data
represent the means6SEM of 8 mice per group.
Found at: doi:10.1371/journal.pone.0000523.s004 (0.04 MB TIF)
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